Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop their ...

Small cell lung cancer (SCLC) is one of the hardest types of cancer to treat and has often already spread by the time people are diagnosed. It mainly arises from neuroendocrine (NE) cells, which help ...

Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop their ...

Researchers have discovered a particular type of cancer cell that relies on its own biological electric utility company to thrive. Disrupting this power plant – with the help of a puffer fish – showed ...

The retired Packers kicker and his family get back to Green Bay whenever they can, often taking one of their favorite local ...

The following is a summary of “Transcriptional regulatory network analysis identifies GRN as a key regulator bridging chemotherapy and immunotherapy response in small cell lung cancer,” published in ...

Over 230 patients enrolled in potential registration-enabling trial in 1L HLA-A2-negative MUM, and median PFS readout targeted by year-end 202595 patients enrolled in neoadjuvant UM trial and ...

AdvanCell is developing therapies to treat cancers including: prostate, skin, pancreatic, breast, bladder, colorectal, kidney ...

We have pancreatic neuroendocrine tumor, GI neuroendocrine tumor, lung neuroendocrine tumor, functional/non-functional neuroendocrine tumors and neuroendocrine tumors enrolled regardless of their ...

The FDA has started a priority review of Amgen’s tarlatamab for small cell lung cancer (SCLC ... including neuroendocrine prostate cancer (in phase 1) and potentially glioblastoma multiforme ...